Literature DB >> 24484574

Management of urinary tract infections from multidrug-resistant organisms.

Kalpana Gupta1, Nahid Bhadelia2.   

Abstract

Antibiotic resistance worsens clinical outcomes and, in some cases, significantly impacts the clinical management of urinary tract infections in the outpatient setting. This article presents the prevalence and mechanism of relevant antimicrobial resistance patterns encountered among uropathogens, and discusses the efficacy of antibiotic regimens and novel therapies in treating commonly encountered multidrug-resistant organisms. Published by Elsevier Inc.

Entities:  

Keywords:  Carbapenem-resistant Enterobacteriaceae; Cystitis; Extended-spectrum β-lactamases; Multidrug-resistant organisms; Vancomycin-resistant Enterococcus

Mesh：

Substances：

Year:  2013        PMID： 24484574     DOI： 10.1016/j.idc.2013.10.002

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN： 0891-5520            Impact factor:   5.982


  29 in total

Review 1.  The Vaginal Microbiota and Urinary Tract Infection.

Authors:  Ann E Stapleton
Journal:  Microbiol Spectr       Date:  2016-12

Review 2.  Urinary tract infections: epidemiology, mechanisms of infection and treatment options.

Authors:  Ana L Flores-Mireles; Jennifer N Walker; Michael Caparon; Scott J Hultgren
Journal:  Nat Rev Microbiol       Date:  2015-04-08       Impact factor: 60.633

3.  Bacterial virulence phenotypes of Escherichia coli and host susceptibility determine risk for urinary tract infections.

Authors:  Henry L Schreiber; Matt S Conover; Wen-Chi Chou; Michael E Hibbing; Abigail L Manson; Karen W Dodson; Thomas J Hannan; Pacita L Roberts; Ann E Stapleton; Thomas M Hooton; Jonathan Livny; Ashlee M Earl; Scott J Hultgren
Journal:  Sci Transl Med       Date:  2017-03-22       Impact factor: 17.956

4.  Catheterization alters bladder ecology to potentiate Staphylococcus aureus infection of the urinary tract.

Authors:  Jennifer N Walker; Ana L Flores-Mireles; Chloe L Pinkner; Henry L Schreiber; Matthew S Joens; Alyssa M Park; Aaron M Potretzke; Tyler M Bauman; Jerome S Pinkner; James A J Fitzpatrick; Alana Desai; Michael G Caparon; Scott J Hultgren
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-25       Impact factor: 11.205

5.  Antimicrobial Resistance Patterns and Dynamics of Extended-Spectrum β-Lactamase-Producing Uropathogenic Escherichia coli in Cusco, Peru.

Authors:  Steev Loyola; Fátima Concha-Velasco; Jimena Pino-Dueñas; Nancy Vasquez-Luna; Paola Juarez; Carlos Llanos; Guillermo Salvatierra; Jesus Tamariz; Andres G Lescano
Journal:  Antibiotics (Basel)       Date:  2021-04-22

6.  The C5a/C5aR1 Axis Contributes to the Pathogenesis of Acute Cystitis Through Enhancement of Adhesion and Colonization of Uropathogenic E. coli.

Authors:  Kun-Yi Wu; Bo Cao; Chun-Xuan Wang; Xue-Ling Yang; Shu-Juan Zhao; Teng-Yue Diao; Li-Rong Lin; Guo-Xiu Zhao; Wuding Zhou; Ju-Rong Yang; Ke Li
Journal:  Front Cell Infect Microbiol       Date:  2022-03-30       Impact factor: 5.293

7.  Molecular Epidemiology of Escherichia coli Producing CTX-M and pAmpC β-Lactamases from Dairy Farms Identifies a Dominant Plasmid Encoding CTX-M-32 but No Evidence for Transmission to Humans in the Same Geographical Region.

Authors:  Jacqueline Findlay; Oliver Mounsey; Winnie W Y Lee; Nerissa Newbold; Katy Morley; Hannah Schubert; Virginia C Gould; Tristan A Cogan; Kristen K Reyher; Matthew B Avison
Journal:  Appl Environ Microbiol       Date:  2020-12-17       Impact factor: 5.005

8.  Inhibition of Cyclooxygenase-2 Prevents Chronic and Recurrent Cystitis.

Authors:  Thomas J Hannan; Pacita L Roberts; Terrence E Riehl; Sjoerd van der Post; Jana M Binkley; Drew J Schwartz; Hiroyuki Miyoshi; Matthias Mack; Reto A Schwendener; Thomas M Hooton; Thaddeus S Stappenbeck; Gunnar C Hansson; William F Stenson; Marco Colonna; Ann E Stapleton; Scott J Hultgren
Journal:  EBioMedicine       Date:  2014-10-24       Impact factor: 8.143

9.  Expression and Significance of the HIP/PAP and RegIIIγ Antimicrobial Peptides during Mammalian Urinary Tract Infection.

Authors:  John David Spencer; Ashley R Jackson; Birong Li; Christina B Ching; Martin Vonau; Robert S Easterling; Andrew L Schwaderer; Kirk M McHugh; Brian Becknell
Journal:  PLoS One       Date:  2015-12-10       Impact factor: 3.240

Review 10.  Vancomycin-resistant enterococcal infections: epidemiology, clinical manifestations, and optimal management.

Authors:  Tristan O'Driscoll; Christopher W Crank
Journal:  Infect Drug Resist       Date:  2015-07-24       Impact factor: 4.003
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.